Hello everyone, here is the top-down analysis for JNJ, feel free to request any pair/instrument or ask any questions in the comment section below. Best of luck!
On 8/7/2020 Brokerage LADENBURG THALM/SH SH Reiterated ACHV Rating to BUY and set the target price to $100.00, now the cost of one share is 9.84usd. You can find the asset on trading212, the most downloaded trading app in the U.K. With a market cap of $15.45 million and a worldwide working product, it`s hard to say ACHV can go lower than that. The only concern is...
Over the last three days, I have detected that RVP's AroonUp green line is above 70, while the AroonDown red line is below 30. When the green line goes above 70 while the red line stays below 30, this is an indicator that the stock could be poised for a strong Uptrend. For traders, this could mean going long the stock or exploring call options in the next month. I...
Zynex, Inc., a medical technology company, designs, manufactures, and markets electrotherapy medical devices used for pain management and rehabilitation.
Looking for .48c entry Tight stop below .45c support @ .44c looking for PT1 .61c RR 3.25 Risking 8.33% for Gains of 27.08% PT2 .75c Risking 8.33% RR 6.75 Gains of 56.25% PT3 Risking 8.33% RR 8.5 Gains of 70.83%
The market atm is pretty boring. Bitcoin is doing nothing, stocks trading on news, Tesla mooning on earnings epectations with possibility of NASDAQ listing, cruise lines crap, and tech stocks booming. Now I been watching NSPR a little trying to find a good time to buy. NSPR is a medical stock that helps certain surgeries possible, yet its downfall is its not sold...
All description on the chart. Please, don't forget to like and follow. Thank you.
This indicator may be signaling that ATEC's price has momentum to move higher, since its current price exceeds the price logged 14 days ago. Traders may consider buying the stock or exploring call options. I backtested 96 similar cases where ATEC's Momentum Indicator exceeded 0, and 81 of them led to a successful outcome. Odds of Success: 84%.
This is a Bullish indicator signaling CDNA's price could rise from here. Traders may explore going long the stock or buying call options. I identified 45 similar cases where CDNA's MACD histogram became positive, and 34 of them led to successful outcomes. Odds of Success: 76%.
$QDEL did a new high, RSI did too. Volume is far above the average. 12 months Consensus Price Target: $117 if you find my charts useful, please leave me "like" or "comment". Please don't trade according to the ideas, rely on your own knowledge. Thx
This is a Bullish indicator signaling CERS's price could rise from here. Traders may explore going long the stock or buying call options. I identified 41 similar cases where CERS's MACD histogram became positive, and 34 of them led to successful outcomes. Odds of Success: 83%.
Retractable Technologies (RVP, $6.24) was one of top quarterly gainers, jumping +442.61% to $6.24 per share. Tickeron A.I.dvisor analyzed 203 stocks in the Medical Specialties Industry over the last three months, and discovered that 191 of them (93.98%) charted an Uptrend while 12 of them (6.02%) trended down. Tickeron A.I.dvisor found 295 similar cases when RVP's...
Another one of these "COVID Stocks" - Decisions, decisions upcoming - take it or leave it at this point. Don't take as financial advice...
Here is an update to yesterday, a quick, sharp ABC recovery has taken place. Time will tell if this results in this being just the first of a more complex ABC or if this restocked the stochastic enough to propel it onward.
I see a cup and handle forecast called out here, which is a possibility with the way the current COVID market is moving. HTBX does have a few bright spots in early faces of trials, one of which for tumor destruction: "PTX-35 is a novel, first-in-class agonist antibody targeting TNFRSF25, also known as death receptor 3 (DR3), a receptor that is preferentially...
Purely for my own use as I've been following this (as well as a few other stocks since COVID surged this market sector) for a couple months now. I see 3 options ahead of us after the immediate rejection today near 3.30 mark. 1) A quick correction before another rise after another bounce off the support 2) A two week correction before a bounce off support to...
GenMark Diagnostics, Inc., a molecular diagnostics company, develops and commercializes molecular panels based on its proprietary eSensor electrochemical detection technology. It provides ePlex instrument and respiratory pathogen panel, which integrates automated nucleic acid extraction and amplification with its eSensor technology to enable operators using ePlex...